Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma

Fig. 3

The association between HSD17B6 expression and survival rates of HCC patients. a–d Kaplan–Meier analysis of OS (Overall survival), PFS (Progression-free survival), RFS (Relapse-free survival) and DSS (Disease specific survival) in the TCGA-LIHC patients based on HSD17B6 expression. e, f Kaplan–Meier analysis of OS (Overall survival) in the patients with HCC based on HSD17B6 expression of GSE14520 and ICGC-LIRI-JP datasets using HCCDB

Back to article page